Compare MAX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAX | SOPH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.1M | 462.3M |
| IPO Year | 2020 | 2021 |
| Metric | MAX | SOPH |
|---|---|---|
| Price | $9.74 | $7.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $15.43 | $9.75 |
| AVG Volume (30 Days) | ★ 676.7K | 566.4K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $1,113,600,000.00 | N/A |
| Revenue This Year | $17.31 | $23.24 |
| Revenue Next Year | $8.70 | $24.63 |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $7.09 | $3.75 |
| 52 Week High | $14.70 | $8.98 |
| Indicator | MAX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 56.88 |
| Support Level | $9.41 | $7.71 |
| Resistance Level | $10.26 | $8.84 |
| Average True Range (ATR) | 0.55 | 0.38 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 23.19 | 64.55 |
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.